John L. Cameron

John L. Cameron

General Surgery | Surgical Oncology
601 North Caroline Street, Floor 8
Floor 8
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 171 publications

Minimally Invasive Versus Open Surgery for Insulinoma: A 20-Year Institutional Experience.

Minimally Invasive Versus Open Surgery for Insulinoma: A 20-Year Institutional Experience.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: February 17, 2026

Incidence of Endocrine and Exocrine Pancreatic Insufficiency after Minimally Invasive Parenchyma-Sparing Pancreatectomy.

Incidence of Endocrine and Exocrine Pancreatic Insufficiency after Minimally Invasive Parenchyma-Sparing Pancreatectomy.

Journal: Journal of the American College of Surgeons
Published: January 14, 2026

Incidental Diagnosis of Pancreatic Cancer and Association with Improved Patient Outcomes: Assessing the Potential Clinical Use of Liquid Biopsy-Based Screening Tests.

Incidental Diagnosis of Pancreatic Cancer and Association with Improved Patient Outcomes: Assessing the Potential Clinical Use of Liquid Biopsy-Based Screening Tests.

Journal: Journal of the American College of Surgeons
Published: December 09, 2025

Management and outcomes for portal venous thrombosis after pancreaticoduodenectomy.

Management and outcomes for portal venous thrombosis after pancreaticoduodenectomy.

Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
Published: June 27, 2025

The Mutational Status of Driver Genes in Patients With Resected Pancreatic Ductal Adenocarcinoma Is Associated With Pathological Characteristics and Overall Survival.

The Mutational Status of Driver Genes in Patients With Resected Pancreatic Ductal Adenocarcinoma Is Associated With Pathological Characteristics and Overall Survival.

Journal: Annals of surgery
Published: June 18, 2025

Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: an Analysis of 904 Patients with 7882 Person-Years of Follow-Up.

Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: an Analysis of 904 Patients with 7882 Person-Years of Follow-Up.

Journal: Endocrine pathology
Published: May 27, 2025

Pancreatic and Peripancreatic Neural Crest-Derived Tumors: An Updated Contemporary Single Center Experience.

Pancreatic and Peripancreatic Neural Crest-Derived Tumors: An Updated Contemporary Single Center Experience.

Journal: Pancreas
Published: May 14, 2025

The impact of perioperative chemotherapy in patients with pancreatic adenosquamous carcinoma.

The impact of perioperative chemotherapy in patients with pancreatic adenosquamous carcinoma.

Journal: Surgery
Published: April 22, 2025

Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: An Analysis of 904 Patients with 7882 Person-Years of Follow-Up.

Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: An Analysis of 904 Patients with 7882 Person-Years of Follow-Up.

Journal: medRxiv : the preprint server for health sciences
Published: April 16, 2025

Ductal Cancerization at the Pancreatic Neck Margin: Prevalence and Oncologic Relevance.

Ductal Cancerization at the Pancreatic Neck Margin: Prevalence and Oncologic Relevance.

Journal: Annals of surgery
Published: March 27, 2025

Association Between Adjuvant Therapy and Survival in Resected Pancreatic Ductal Adenocarcinoma After Different Types and Durations of Neoadjuvant Therapy.

Association Between Adjuvant Therapy and Survival in Resected Pancreatic Ductal Adenocarcinoma After Different Types and Durations of Neoadjuvant Therapy.

Journal: Annals of surgical oncology
Published: January 16, 2025

Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcinoma.

Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcinoma.

Journal: Annals of surgery
Published: September 04, 2024
Showing 1-12 of 171

Last Updated: 09/26/2026